SKBS revenue breakdown overview

SKBS revenue for the last year amounted to 369.75 B KRW, the most of which — 369.51 B KRW — came from its highest performing source at the moment, Vaccine/Biopharmaceuticals, the year earlier bringing 456.73 B KRW. The greatest contribution to the revenue figure was made by America — last year it brought SKBS 185.96 B KRW, and the year before that — 217.83 B KRW.